NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-286-2006-2-US-02 SCGB3A2 As A Growth Factor and Anti-Apoptotic Agent US National Stage 12/442,927 8133859 Issued PDF
NIAID E-146-2008-2-PCT-01 Induction Of Profliferation, Molecule Expression And Cytolytic Capacity Of HIV -Specific CD8 + T Cells PCT PCT COMB PCT/US2009/001859 Expired
NCI E-079-2008-0-PCT-02 Human Anti-Mesothelin Monoclonal Antibodies PCT PCT PCT/US2009/038228 Expired
NIAID E-146-2008-2-EP-02 Induction Of Profliferation, Effector Molecule Expression And Cytolytic Capacity Of HIV -Specific CDS+ T Cells EP National Stage 09762793.9 Abandoned
NCI E-079-2008-0-EP-05 Human Anti-Mesothelin Monoclonal Antibodies EP National Stage 09726082.2 Abandoned
NCI E-079-2008-0-AU-03 Human Anti-Mesothelin Monoclonal Antibodies AU National Stage 2009228361 Abandoned
NCI E-079-2008-0-CA-04 Human Anti-Mesothelin Monoclonal Antibodies CA National Stage 2718321 Abandoned
NIDDK E-140-2008-0-CA-04 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists CA National Stage 2720037 Issued
NIDDK E-140-2008-0-GB-10 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists GB EP 09728154.7 Issued
NIDDK E-140-2008-0-ES-08 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists ES EP 09728154.7 Issued
NIDDK E-140-2008-0-IT-11 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists IT EP 09728154.7 Issued
NIDDK E-140-2008-0-FR-09 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists FR EP 09728154.7 Issued
NIDDK E-140-2008-0-DE-07 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists DE EP 09728154.7 Issued
NIDDK E-140-2008-0-EP-05 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists EP National Stage 09728154.7 Issued
NIDDK E-140-2008-0-AU-03 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists AU National Stage 2009231978 Issued
NIDDK E-140-2008-0-PCT-02 Design Of (N)-Methanocarba Adenosine 5'Uronamides As Species-Independent A3 Receptor-Selective Agonists PCT PCT PCT/US2009/038026 Expired
NCI E-091-2009-0-US-01 Human Monoclonal Antibody Variable Fragments (Fvs) To Mesothelin US 61/162,778 Abandoned
NIDDK E-308-2006-3-US-01 Cross-Coupled Peptide Nucleic Acids For Detection Of Nucleic Acids Of Pathogens US CIP 12/409,159 Abandoned
NCI E-311-2006-1-US-03 Compositions And Methods For Chitosan Enhanced Immune Response US National Stage 12/442,483 Abandoned
NIAID E-150-2009-0-US-01 Discovery Of Novel Pharmacophores Inhibiting The Growth Of Mycobacterium Tuberculosis US 61/162,588 Abandoned
NCI E-317-2008-0-PCT-01 Renal Cell Carcinoma Biomarkers PCT PCT PCT/US2009/037855 Expired
NIAID E-053-2008-1-PCT-01 Aerosolized Vaccines PCT PCT COMB PCT/US2009/001754 Expired
NIDDK E-151-2009-0-US-01 Nucleic Acids For The Detection Of Pathogens US 61/162,175 Abandoned
NIDDK E-109-2009-0-US-01 Inhibitors of Viral Integrase and Methods of Use Thereof US 61/161,469 Abandoned
NICHD E-146-2009-0-US-01 Carboxypeptidase E-gammaN Biomarker For Determining Metastasis And Predicting Recurrence Of Paragangliomas And Differentiated Thyroid Carcinomas US 61/161,568 Abandoned
NCI E-287-2009-2-US-01 Antiproliferative Factors And Methods Of Use US 61/161,349 Abandoned
NIAID E-148-2009-0-US-01 Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer US 61/161,223 Abandoned
NCI E-167-1997-0-JP-25 The Use of Nitroxide or a Prodrug Thereof In The Prophylactic And Therapeutic Treatment of Cancer JP DIV 2009-062262 Abandoned
NCI E-191-2002-0-US-08 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF. US DIV 12/402,560 Abandoned
NCI E-158-2005-0-US-03 Peptide Epitopes Of Vegfr-2/Kdr that Inhibit Angiogenesis US CON 12/402,401 8378071 Abandoned PDF
NIAID E-357-2001-1-JP-09 Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus JP DIV 2009-058277 Abandoned
NINDS E-143-2002-0-US-08 METHOD OF TREATING AUTOIMMUNE DISEASES WITH INTERFERON-BETA AND IL-2R ANTAGONIST US CON 12/401,543 8298525 Abandoned PDF
NHLBI E-141-2009-0-US-01 Magnetic Resonance Imaging Method and Apparatus for High-Resolution SpatiaI and Temporal Data- Driven Reconstructions ("Self-Navigating" or "Self-Gating") US 61/158,503 Abandoned
NIAID E-089-2002-1-US-09 Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 US CON 12/398,043 8075903 Expired PDF
NHLBI E-048-2009-0-US-01 Cerclage Locking Device And Delivery System US 61/157,267 Abandoned
NIAID E-319-2004-2-US-11 Optimized Vaccines To Provide Protection Against Ebola And Other Viruses US National Stage 11/662,869 8101739 Issued PDF
NIAID E-120-2001-0-US-13 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US CON 12/396,376 8039003 Expired PDF
NIDDK E-291-1998-0-US-06 Immune Activation by Double-Stranded Polynucleotides US DIV 12/396,468 Abandoned
NCI E-340-2007-0-EP-10 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS EP DIV 14170625.9 Abandoned
NCI E-340-2007-0-GB-25 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS GB EP 14170625.9 Abandoned
NCI E-340-2007-0-IT-26 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS IT EP 14170625.9 Issued
NCI E-340-2007-0-CH-21 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS CH EP 14170625.9 Abandoned
NCI E-340-2007-0-ES-23 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS ES EP 14170625.9 Abandoned
NCI E-340-2007-0-FR-24 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS FR EP 14170625.9 Abandoned
NCI E-340-2007-0-DE-22 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS DE EP 14170625.9 Abandoned
NCI E-340-2007-0-AU-05 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS AU National Stage 2009219197 Abandoned
NCI E-340-2007-0-CN-06 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS CN National Stage 200980111708.1 Abandoned
NCI E-144-2002-0-AU-08 IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES AU DIV 2009200792 Abandoned
NCI E-340-2007-0-PCT-02 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS PCT PCT PCT/US2009/035470 Expired
NCI E-340-2007-0-US-07 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders US National Stage 12/919,888 Abandoned